Analyst Downgrades – NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR) Stock Gets Downgraded By HC Wainwright from Buy ➝ Neutral to

ME Staff
-
0

Analyst Ratings For NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR)

Today, NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR) stock was downgraded by HC Wainwright from Buy ➝ Neutral to with a price target of $54.00.

Some recent analyst ratings include

  • 6/11/2018-HC Wainwright was Downgraded by analysts at HC Wainwright from a “Buy ➝ Neutral” rating to a “” rating. They now have a $54.00 price target on the stock.
  • 6/4/2018-William Blair Reiterated Rating of Buy.
  • 4/20/2018-Seaport Global Securities initiated coverage with a Buy rating.
  • 4/17/2018-Mizuho Reiterated Rating of Buy.

Recent Insider Trading Activity For NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR)
NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR) has insider ownership of 4.31% and institutional ownership of 90.84%.

  • On 6/6/2018 R Scott Greer, Director, sold 10,000 with an average share price of $60.28 per share and the total transaction amounting to $602,800.00.
  • On 6/4/2018 R Scott Greer, Director, sold 1,400 with an average share price of $61.99 per share and the total transaction amounting to $86,786.00.
  • On 5/16/2018 Gil M. Labrucherie, CFO, sold 4,941 with an average share price of $83.39 per share and the total transaction amounting to $412,029.99.
  • On 5/16/2018 Howard W Robin, CEO, sold 12,791 with an average share price of $83.39 per share and the total transaction amounting to $1,066,641.49.
  • On 5/16/2018 Jillian B. Thomsen, CAO, sold 3,576 with an average share price of $83.39 per share and the total transaction amounting to $298,202.64.
  • On 5/16/2018 John Nicholson, COO, sold 4,917 with an average share price of $83.39 per share and the total transaction amounting to $410,028.63.
  • On 5/16/2018 Stephen K Doberstein, SVP, sold 3,435 with an average share price of $83.39 per share and the total transaction amounting to $286,444.65.

Recent Trading Activity for NASDAQ:NKTR – Nektar Therapeutics (NASDAQ:NKTR)
Shares of NASDAQ:NKTR – Nektar Therapeutics closed the previous trading session at 53.38 down -0.76 1.40% with 52.84000015258789 shares trading hands.